Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein
1997
Indomethacin Reverses Drug Resistance in Cancer Cells
publication
Evidence: moderate
Author Information
Author(s): MP Draper, RL Martell, SB Levy
Primary Institution: Tufts University School of Medicine
Hypothesis
Can indomethacin modulate multidrug resistance in cancer cells overexpressing MRP?
Conclusion
Indomethacin increases drug accumulation and sensitivity in MRP-overexpressing cancer cells.
Supporting Evidence
- Indomethacin increased BCECF accumulation in MRP-expressing cell lines.
- Indomethacin did not affect P-glycoprotein-mediated drug export.
- Indomethacin enhanced sensitivity to vincristine and doxorubicin in resistant cell lines.
Takeaway
Indomethacin is a medicine that helps some cancer cells take in more drugs, making them more sensitive to treatment.
Methodology
The study involved cell culture, fluorescence measurements, and drug susceptibility assays using MTT.
Limitations
The specific mechanism of indomethacin's action on MRP remains unclear.
Statistical Information
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website